SOSV

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Vaartani is a technology company based in Madrid, Spain, founded in 2018. The company specializes in developing AI-powered solutions for eCommerce businesses, focusing on insurance coverage tailored to the unique risks of online sellers. Vaartani's platform allows Amazon sellers to obtain commercial general liability insurance quotes quickly by simply providing their store name, thanks to its proprietary AI underwriting technology. Additionally, Vaartani offers tools for analyzing customer feedback and answering queries related to food products, enabling food producers to gain valuable insights into their offerings. Overall, Vaartani seeks to streamline the insurance process for eCommerce businesses while enhancing product insight capabilities.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Mybrana is a technology company based in Valencia, Spain, specializing in augmented reality (AR) and computer vision. Founded in 2012, Mybrana has developed a graphics engine that incorporates features such as face recognition and 3D location mapping. This technology empowers brands to launch interactive AR campaigns, allowing for innovative advertising and shopping experiences in both social networks and urban environments. By focusing on creative video creation and sharing, Mybrana aims to redefine advertising formats and enhance product visibility for brands. The company aspires to become a leading reference in the next generation of advertising and shopping platforms.

Mybrana is a technology company based in Valencia, Spain, specializing in augmented reality (AR) and computer vision. Founded in 2012, Mybrana has developed a graphics engine that incorporates features such as face recognition and 3D location mapping. This technology empowers brands to launch interactive AR campaigns, allowing for innovative advertising and shopping experiences in both social networks and urban environments. By focusing on creative video creation and sharing, Mybrana aims to redefine advertising formats and enhance product visibility for brands. The company aspires to become a leading reference in the next generation of advertising and shopping platforms.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

WHO WE ARE: Zartis is a digital solutions provider specialised in building cutting-edge software with bespoke development teams. We know good code. And we know nearshore outsourcing, which can be risky when you don't know who to trust. Deep technical experience and hard-earned know-how are our secret ingredients to help you build game-changing software technology while avoiding unnecessary time and budget-wasting engineering shortfalls. Joining the team in one of our global offices in Cork, London, Berlin, Wroclaw, Valencia and Madrid is a big deal. We are a diverse company, with team members drawn from nineteen different nationalities. WHAT WE DO: Zartis partners with firms across e-commerce, financial services, medtech, media, logistics technology, renewable energy, edtech and more. Our engineering hubs in Ireland, Spain, and Poland are full of really clever people delivering business success and digital improvement across application development, software architecture, CI/CD, business intelligence, QA automation and new technology integrations. OUR EXPERTISE: Zartis engineers are uniquely skilled in a broad array of technologies such as JavaScript (Angular, React, Vue), .NET, Java, Python, Scala, Ruby, Go, and cloud-based architectures like AWS, Azure, and Google Cloud. And we manage the whole delivery chain, so there's no added headache.